| Literature DB >> 34900479 |
Sean Fang1, Vasileios Gkiousias1, Lisi Hu1, Karan Kapoor1.
Abstract
Rapidly expanding thyroid lesions with tracheal invasion are typical characteristics of anaplastic and undifferentiated thyroid carcinomas, but primary thyroid lymphoma (PTL) must also be considered as a differential. Aggressive thyroid lesions can compromise the airway through compression and/or direct invasion of the tracheal wall. We present a rare case of PTL in a 57-year-old female patient who presented with worsening orthopnoea and hoarseness, followed by shortness of breath, secondary to direct invasion and compression of the trachea resulting in pulmonary edema and cardiomyopathy, requiring intensive care input. In view of the extent of the disease and associated repercussions, the patient underwent total thyroidectomy and chemotherapy, as part of her therapeutic regime, with metabolic and cardiovascular remission achieved. Histological diagnosis confirmed diffuse large B-cell lymphoma (DLBCL). PTL is a rare condition, with few cases reported in the literature. Fine needle aspiration cytology (FNAC) used traditionally in the diagnosis of thyroid lesions is less informative in PTL and core needle and incisional biopsy techniques, coupled with CT, can provide diagnostic clarity. Due to the unusual nature of PTL, it can pose diagnostic and management difficulties. Further studies are required and a multi-professional tailored approach should be adopted for each patient until a therapeutic consensus can be reached.Entities:
Keywords: cardiomyopathy; cardiopulmonary compromise; primary thyroid lymphoma; thyroid; tracheal invasion
Year: 2021 PMID: 34900479 PMCID: PMC8649979 DOI: 10.7759/cureus.19302
Source DB: PubMed Journal: Cureus ISSN: 2168-8184
Figure 1CT neck with contrast scan showing large thyroid lesion with significant tracheal compression, resulting in a minimal lumen size of 6 mm, without direct tracheal invasion.
Figure 2CT neck with contrast scan performed post total thyroidectomy and three cycles of R-CHOP chemotherapy, demonstrating marked regression of the previously visualized thyroid lesion and resolved airway compromise.